|
CAS-Nr. | 27063-93-0 |
Bezeichnung: | |
Englisch Name: | 3-BROMO-2,4-DIMETHYLPYRIDINE |
Synonyma: | 3-BroMo-2,4-lutidine;3-BROMO-2,4-DIMETHYLPYRIDINE;3-Bromo-2,4-Dimethylpiperidine;PYRIDINE, 3-BROMO-2,4-DIMETHYL |
CBNumber: | CB02451679 |
Summenformel: | C7H8BrN |
Molgewicht: | 186.05 |
MOL-Datei: | 27063-93-0.mol |
|
|
|
|
3-BROMO-2,4-DIMETHYLPYRIDINE physikalisch-chemischer Eigenschaften |
|
3-BROMO-2,4-DIMETHYLPYRIDINE Chemische Eigenschaften,Einsatz,Produktion Methoden |
|
3-BROMO-2,4-DIMETHYLPYRIDINE Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
3-BROMO-2,4-DIMETHYLPYRIDINE Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 20)Lieferanten |
Firmenname | Telefon | Fax | E-Mail | Land | Produktkatalog | Edge Rate |
JinYan Chemicals(ShangHai) Co.,Ltd.
| 13817811078,021-50426030 | 86-021-50426522,50426273 | sales@jingyan-chemical.com | CHINA |
10108
|
60
|
ChengDu TongChuangYuan Pharmaceutical Co.Ltd
| 028-83379370,13880556291 | 028-87747383 | tcy@tcypharm.com | CHINA |
676
|
57
|
Pure Chemistry Scientific Inc.
| 001-857-928-2050 or 1-888-588-9418 | 001-617-206-9595 | sales@chemreagents.com | USA |
9949
|
62
|
Chemfun Medical Technology(Shanghai) Co., Ltd.
| 021-67220633 & 021-37212706 | +86-21-67220638 | chemfun@chemfun.net | CHINA |
21915
|
59
|
Syntechem Co.,Ltd
| Skype: syntechem18 | QQ 956912955 | qyh@syntechem.com we provide custom synthesis | CHINA |
29756
|
57
|
Shanghai Sunway Pharmaceutical Technology Co., Ltd
| +86 (21) 51613915 | +86 (21) 51613951 | sales@sunwaypharm.com | CHINA |
10114
|
57
|
Shanghai T&W Pharmaceutical Co., Ltd.
| +86 21 61551611 | +86 21 50676805 | contact@trustwe.com | CHINA |
9988
|
58
|
Shanghai Raise Chemical Technology Co.,Ltd
| +86-021-50935922, 021-31250975 | +86-021-33847795 | rs@raise-chem.com | CHINA |
9355
|
55
|
Bide Pharmatech Ltd.
| +86-21-61629020 | +86-21-61629029 | product@bidepharmatech.com | CHINA |
40303
|
60
|
Synchem OHG
| +49 5662 408730 | +49 5662 4087320 | info@synchem.de | GERMANY |
4701
|
70
|
|
|
|
|